FINISHED DOSAGE FORMULATIONS
Drug : VANIQA
Dosage Form : CREAM; TOPICAL
Application Number : 21145
Country : US
Patented : No
PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)
Drug : CREON
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 20725
Country : US
Patented : No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 78279
Country : US
Patented : No
Drug : NYSTATIN
Dosage Form : CREAM; TOPICAL
Application Number : 65315
Country : US
Patented : No
Drug : DUTASTERIDE
Dosage Form : CAPSULE; ORAL
Application Number : 208227
Country : US
Patented : No
Drug : ASPIRIN AND DIPYRIDAMOLE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 78804
Country : US
Patented : No
Drug : MIRENA
Dosage Form : SYSTEM; INTRAUTERINE
Application Number : 21225
Country : US
Patented : Yes
Drug : DIMETHYL FUMARATE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 210305
Country : US
Patented : No
Drug : NYSTATIN
Dosage Form : CREAM; TOPICAL
Application Number : 61966
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
Dosage Form : Cream / Lotion / Ointment, Suspension
Grade : Topical
Category : Thickeners and Stabilizers
Application : Thickeners and Stabilizers
Excipient Details : Silfoam® SE 2 is used as a thickener and a viscosity modifier in liquid and topical dosage forms.
Application : Direct Compression
Excipient Details : DC SIM 100 is a directly compressible simethicone powder used for antacid and anti-gas tablets.
Application : Rheology Modifiers
Excipient Details : Silfoam® SE 2 is used as a thickener and a viscosity modifier in liquid and topical dosage forms.
MARKET PLACE
Reply
31 Dec 2024
Reply
20 Dec 2024
Reply
02 Mar 2024